EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study

Megan E B Clowse, Radboud J E M Dolhain, Stephanie Finzel, Frauke Förger, Cornelia Glaser, Andrea Pluma, Laura Shaughnessy, Jagdev Sidhu, Jemma Greenin, Kathy Rice, Gauri Utturkar, Joao N Duarte und 1 weitere

Rheumatology and Therapy · 2026-06 · 13 (3) · 813-828

DOI: 10.1007/s40744-026-00853-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology and Therapy, online erschienen am 21.04.2026. Verfasst von Megan E B Clowse und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Rheumatology and Immunology, Duke University, Baker House 07, Duke South, Trent Drive, Durham, NC, 27710, USA. me…. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: UCB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Certolizumab pegolInflammatory diseasesPharmacokineticsPregnancyWomen of childbearing age

Autor:innen und Institutionen

  • Department of Medicine, Division of Rheumatology and Immunology, Duke University, Baker House 07, Duke South, Trent Drive, Durham, NC, 27710, USA. megan.clowse@duke.edu.
  • Department of Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Rheumatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Department of Rheumatology, Vall d'Hebron University Hospital, Barcelona, Spain.

Förderung

  • UCB

Zitieren

APA

Clowse, M. E. B., Dolhain, R. J. E. M., Finzel, S., Förger, F., Glaser, C., Pluma, A., Shaughnessy, L., Sidhu, J., Greenin, J., Rice, K., Utturkar, G., Duarte, J. N., & Teil, M. (2026). Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study. Rheumatology and Therapy, 13(3), 813-828. https://doi.org/10.1007/s40744-026-00853-2

Vancouver

Clowse MEB, Dolhain RJEM, Finzel S, Förger F, Glaser C, Pluma A, et al. Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study. Rheumatology and Therapy. 2026;13(3):813-828. doi:10.1007/s40744-026-00853-2

BibTeX
@article{Clowse2026,
  author = {Clowse, Megan E B and Dolhain, Radboud J E M and Finzel, Stephanie and Förger, Frauke and Glaser, Cornelia and Pluma, Andrea and Shaughnessy, Laura and Sidhu, Jagdev and Greenin, Jemma and Rice, Kathy and Utturkar, Gauri and Duarte, Joao N and Teil, Marie},
  title = {Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study},
  journal = {Rheumatology and Therapy},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {813--828},
  doi = {10.1007/s40744-026-00853-2}
}
Kostenlos starten →